φ(ai) PHI AI
DocumentationDocs
Repository
In context Ashlee Leon Mann MRN-100739 · born 1983-02-23 ✦ AI Ask ✦ AI Ambient note Chart
Chart · view recorded under the Health care operations purpose
Ashlee Leon Mann MRN-100739 Born Feb 23, 1983 (43) Sex female Payer Medicare Acton, MA
AI summary drafted by claude-sonnet-5 from this record · verify against the chart

Ashlee Leon Mann is a 43-year-old female with chronic congestive heart failure, first diagnosed in early 2025, managed with lisinopril, furosemide, carvedilol, and losartan. She also has a history of obesity, anemia, prediabetes, and intimate partner abuse victimization, with ongoing follow-up encounters for her cardiac condition into 2026.

Drives care
  • Chronic congestive heart failure
  • Obesity (BMI 30+)
  • Anemia
  • Prediabetes
Watch
  • Persistent BMI at 30.0 kg/m2 across multiple years with no documented improvement
  • Overlapping ACE inhibitor (lisinopril) and ARB (losartan) therapy - verify indication/duplication
  • History of intimate partner abuse - confirm safety status and support resources
Withheld from this view and from assistant retrieval: 8 × Reproductive health · 2 × Mental health. Sensitive-category records exist and are counted, never silently absent — reaching them takes the dedicated role and path, and every access is audited as a disclosure. Your psychotherapy role can open the notes below.

Active problems

ConditionStatusOnset
Chronic congestive heart failure (disorder) active Jan 9, 2025
Body mass index 30+ - obesity (finding) active Jan 21, 2020
Victim of intimate partner abuse (finding) active Jan 21, 2020
Anemia (disorder) active Jan 17, 2017
Prediabetes (finding) active Jan 14, 2014

Active medications

MedicationDosageSince
lisinopril 20 MG Oral TabletTake as needed. Jan 24, 2026
Furosemide 40 MG Oral TabletTake as needed. Nov 11, 2025
carvedilol 25 MG Oral TabletTake as needed. Nov 11, 2025
losartan potassium 50 MG Oral TabletTake as needed. Nov 11, 2025
Vitamin B12 5 MG/ML Injectable Solution Jan 24, 2017

Allergies

SubstanceReactionVerification
No known allergies recorded.

Recent results

TestValueWhen
Potassium 4.46 mmol/L Jan 24, 2026
Sodium 137.58 mmol/L Jan 24, 2026
Glucose 94.49 mg/dL Jan 24, 2026
Potassium 3.72 mmol/L Nov 11, 2025
Sodium 142.97 mmol/L Nov 11, 2025
Glucose 65.31 mg/dL Nov 11, 2025
Respiratory rate 16 /min Nov 11, 2025
Heart rate 97 /min Nov 11, 2025
BMI 27.87 kg/m2 Nov 11, 2025
Body weight 75.9 kg Nov 11, 2025
Pain severity 3 {score} Nov 11, 2025
Body height 165 cm Nov 11, 2025
Hemoglobin A1c 6.05 % Nov 11, 2025
Potassium 4.43 mmol/L Jul 28, 2025
Sodium 136.7 mmol/L Jul 28, 2025
Glucose 98.28 mg/dL Jul 28, 2025
Potassium 4.23 mmol/L Jan 29, 2025
Sodium 141.55 mmol/L Jan 29, 2025
Glucose 85.82 mg/dL Jan 29, 2025
Hemoglobin A1c 6.06 % Jan 9, 2025
HDL cholesterol 59.59 mg/dL Jan 9, 2025
LDL cholesterol 87.19 mg/dL Jan 9, 2025
Triglycerides 114.88 mg/dL Jan 9, 2025
Total cholesterol 169.76 mg/dL Jan 9, 2025
eGFR 110.2 mL/min Jan 9, 2025
Creatinine 0.95 mg/dL Jan 9, 2025
Hemoglobin 12.28 g/dL Jan 9, 2025
WBC 4.813 10*3/uL Jan 9, 2025
Body weight 81.6 kg Jan 9, 2025
HDL cholesterol 54.11 mg/dL Nov 5, 2024

Notes & documents

DocumentAuthorDate
No unrestricted documents.

Claims

ClaimPayerDateStatus BilledPaid
CLM-2026077001Medicare Apr 12, 2026 paid $142.58 $0.00 Lines
CLM-2026077000Medicare Apr 12, 2026 paid $229.32 $0.00 Lines
CLM-2026077003Medicare Jan 24, 2026 paid $2,176.01 $1,672.37 Lines
CLM-2026077002Medicare Jan 24, 2026 paid $129.94 $0.00 Lines
CLM-2026077004Medicare Nov 25, 2025 paid $157.12 $57.26 Lines
CLM-2026077007Medicare Nov 11, 2025 paid $129.94 $0.00 Lines
CLM-2026077006Medicare Nov 11, 2025 paid $39.07 $0.00 Lines
CLM-2026077005Medicare Nov 11, 2025 paid $129.94 $0.00 Lines

Documentation drafts — this patient

No drafts for this patient yet. Ambient notes and AI-drafted documents land here, on the chart they belong to — and in the cross-patient Signature queue.

Imaging

StudyModalityDateSeries / images
synthetic CR previewCR study CR Jan 9, 2025 1 / 1 Open viewer
synthetic US previewUS study US Jan 29, 2025 1 / 1 Open viewer
synthetic US previewUS study US Jul 28, 2025 1 / 1 Open viewer
synthetic US previewUS study US Jan 24, 2026 1 / 1 Open viewer